Antibody responses to the RTS,S/AS01
Adaptive immunity
Malaria
Vaccines
Journal
NPJ vaccines
ISSN: 2059-0105
Titre abrégé: NPJ Vaccines
Pays: England
ID NLM: 101699863
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
11
2019
accepted:
07
05
2020
entrez:
19
6
2020
pubmed:
19
6
2020
medline:
19
6
2020
Statut:
epublish
Résumé
The RTS,S/AS01
Identifiants
pubmed: 32550014
doi: 10.1038/s41541-020-0192-7
pii: 192
pmc: PMC7272643
doi:
Types de publication
Journal Article
Langues
eng
Pagination
46Subventions
Organisme : NIAID NIH HHS
ID : R01 AI095789
Pays : United States
Organisme : Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)
ID : CD010/00156
Commentaires et corrections
Type : ErratumIn
Type : ErratumIn
Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare no competing interests.
Références
Lancet Infect Dis. 2015 Dec;15(12):1450-8
pubmed: 26342424
J Allergy Clin Immunol. 2011 Mar;127(3):616-22.e1
pubmed: 21251701
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
PLoS One. 2011;6(10):e25779
pubmed: 22022448
Malar J. 2018 Jun 1;17(1):219
pubmed: 29859096
Vaccine. 2020 Jan 22;38(4):897-906
pubmed: 31708182
PLoS One. 2009;4(2):e4383
pubmed: 19198649
PLoS Med. 2014 Jul 29;11(7):e1001685
pubmed: 25072396
Cochrane Database Syst Rev. 2013 Dec 09;(12):CD008846
pubmed: 24318836
Lancet Infect Dis. 2011 Oct;11(10):741-9
pubmed: 21782519
BMC Med. 2019 Feb 25;17(1):45
pubmed: 30798787
Nat Commun. 2019 May 15;10(1):2174
pubmed: 31092823
Infect Immun. 2003 Oct;71(10):5549-55
pubmed: 14500473
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1179-84
pubmed: 25583518
BMC Med. 2019 Aug 14;17(1):157
pubmed: 31409398
Immunity. 2012 Nov 16;37(5):771-83
pubmed: 23159225
Front Immunol. 2019 Mar 15;10:439
pubmed: 30930896
Mol Cell Proteomics. 2015 Mar;14(3):519-31
pubmed: 25547414
Malar J. 2017 Aug 5;16(1):314
pubmed: 28779755
J Immunol Methods. 2018 Apr;455:41-54
pubmed: 29397157
N Engl J Med. 2011 Nov 17;365(20):1863-75
pubmed: 22007715
Sci Rep. 2017 Aug 11;7(1):7998
pubmed: 28801554
Lancet Infect Dis. 2019 Aug;19(8):821-832
pubmed: 31300331
Acta Trop. 2015 Feb;142:47-56
pubmed: 25446174
Clin Vaccine Immunol. 2009 Dec;16(12):1709-19
pubmed: 19793898
Hum Vaccin. 2010 Jan;6(1):90-6
pubmed: 19806009
Cell Host Microbe. 2016 Jul 13;20(1):60-71
pubmed: 27374406
BMC Med. 2018 Apr 30;16(1):61
pubmed: 29706136
Malar J. 2016 May 31;15:301
pubmed: 27245446
J Infect Dis. 2011 Jul 1;204(1):9-18
pubmed: 21628653
Malar J. 2008 Sep 24;7:186
pubmed: 18816374
Cell Host Microbe. 2018 Jul 11;24(1):43-56
pubmed: 30001524
Mol Immunol. 2015 Oct;67(2 Pt A):171-82
pubmed: 25900877
JCI Insight. 2017 Nov 2;2(21):
pubmed: 29093263
Infect Immun. 2014 Jan;82(1):152-64
pubmed: 24126527
J Infect. 2015 Jun;71 Suppl 1:S112-20
pubmed: 25934325
Clin Vaccine Immunol. 2013 Sep;20(9):1388-95
pubmed: 23825195
Lancet. 2004 Oct 16-22;364(9443):1411-20
pubmed: 15488216
Hum Vaccin Immunother. 2020 Jan 17;:1-7
pubmed: 31951771
Infect Immun. 2000 Mar;68(3):1252-8
pubmed: 10678934
PLoS One. 2017 Nov 14;12(11):e0187901
pubmed: 29136653
Lancet. 2015 Jul 4;386(9988):31-45
pubmed: 25913272
PLoS One. 2015 Jul 06;10(7):e0132053
pubmed: 26147473
BMC Med. 2018 Oct 31;16(1):197
pubmed: 30376866